-transparent.png){kind=logo}
A 400-mg dose of the trifluorinated quinolone Ro 23-6240 was administered orally to each of six healthy male volunteers, after which the concentrations of this agent in serum and cantharidin-induced inflammatory fluid were measured. Absorption was rapid, with a mean peak level in serum of 6.1 micrograms/ml, which was attained 0.71 h after administration. The elimination half-life in serum was 11.95 h. The agent penetrated the inflammatory fluid rapidly; the percent penetration was 89.7%. Urinary recovery of Ro 23-6240 was 58.6% by 72 h.
Related Publications
R Wise, and
B Kirkpatrick, and
J Ashby, and
D J Griggs
June 1987,
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
R Wise, and
B Kirkpatrick, and
J Ashby, and
D J Griggs
January 1987,
Drugs under experimental and clinical research,
R Wise, and
B Kirkpatrick, and
J Ashby, and
D J Griggs
July 1987,
Antimicrobial agents and chemotherapy,
R Wise, and
B Kirkpatrick, and
J Ashby, and
D J Griggs
June 1987,
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
R Wise, and
B Kirkpatrick, and
J Ashby, and
D J Griggs
January 1987,
Chemotherapy,
R Wise, and
B Kirkpatrick, and
J Ashby, and
D J Griggs
April 1986,
Antimicrobial agents and chemotherapy,
R Wise, and
B Kirkpatrick, and
J Ashby, and
D J Griggs
April 1987,
Diagnostic microbiology and infectious disease,
R Wise, and
B Kirkpatrick, and
J Ashby, and
D J Griggs
September 1987,
The Journal of antimicrobial chemotherapy,
R Wise, and
B Kirkpatrick, and
J Ashby, and
D J Griggs
January 1988,
Chemotherapy,
R Wise, and
B Kirkpatrick, and
J Ashby, and
D J Griggs
April 1987,
European journal of clinical microbiology,
